Filtros de búsqueda

Lista de obras de Atul Deodhar

A systematic review and network meta-analysis of current and investigational treatments for active ankylosing spondylitis

artículo científico publicado en 2020

Axial spondyloarthritis in the USA: diagnostic challenges and missed opportunities

artículo científico publicado en 2018

Effect of secukinumab on clinical and radiographic outcomes in ankylosing spondylitis: 2-year results from the randomised phase III MEASURE 1 study ⬇️

artículo científico publicado en 2016

Elephant in the room

artículo científico publicado en 2018

GRAPPA 2015 Research and Education Project Reports

artículo científico publicado en 2016

Guselkumab, a Selective Interleukin‐23 p19 Subunit Inhibitor, Resolves Dactylitis in Patients With Active Psoriatic Arthritis: Pooled Results Through Week 52 From Two Phase 3 Studies

artículo científico publicado en 2023

Impact of guselkumab, an interleukin-23 p19 subunit inhibitor, on enthesitis and dactylitis in patients with moderate to severe psoriatic arthritis: results from a randomised, placebo-controlled, phase II study

artículo científico publicado en 2020

Incidence of Uveitis in Secukinumab-treated Patients With Ankylosing Spondylitis: Pooled Data Analysis From Three Phase 3 Studies

scientific article published on 30 April 2020

Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective analysis of pooled data from 21 clinical trials

scientific article published on 23 January 2019

Ixekizumab Improves Patient-Reported Outcomes in Non-Radiographic Axial Spondyloarthritis: Results from the Coast-X Trial

artículo científico publicado en 2020

Rebuttal letter to Dr. Fallahi's letter about our manuscript "Axial spondyloarthritis in the USA: diagnostic challenges and missed opportunities." Clin Rheumatol. 2018 Dec 26. https://doi.org/10.1007/s10067-018-4397-3

artículo científico publicado en 2019

Secukinumab Provides Sustained Reduction in Fatigue in Patients with Ankylosing Spondylitis: Long-term Results of Two Phase III Randomized Controlled Trials

scientific article published on 23 November 2020

Secukinumab efficacy in anti-TNF-naive and anti-TNF-experienced subjects with active ankylosing spondylitis: results from the MEASURE 2 Study

artículo científico publicado en 2016

Secukinumab improves signs and symptoms of non-radiographic axial spondyloarthritis: primary results of a randomized controlled phase III study

artículo científico publicado en 2020

Short-term changes on MRI predict long-term changes on radiography in rheumatoid arthritis: an analysis by an OMERACT Task Force of pooled data from four randomised controlled trials ⬇️

artículo científico publicado en 2016

The term 'non-radiographic axial spondyloarthritis' is much more important to classify than to diagnose patients with axial spondyloarthritis

artículo científico publicado en 2016

Tofacitinib in patients with ankylosing spondylitis: a phase II, 16-week, randomised, placebo-controlled, dose-ranging study

artículo científico publicado en 2017

Tumor necrosis factor inhibitors prevent structural damage in hips in ankylosing spondylitis-time to reconsider treatment guidelines? A case series and review of literature

artículo científico publicado en 2020

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda